Aarkstore - GeneScience Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014

1
GeneScience Pharmaceuticals Co., Ltd. - Product
Pipeline Review - 2014
Category Pharmaceuticals Healthcare

• Browse Complete Report -
• http//www.aarkstore.com/pharmaceuticals-healthcar
  e/63684/genescience-pharmaceuticals-co-ltd-product
  -pipeline-review

2
GeneScience Pharmaceuticals Co., Ltd. - Product
Pipeline Review - 2014
3
Summary

• Global Markets Directs, GeneScience
  Pharmaceuticals Co., Ltd. - Product Pipeline
  Review - 2014, provides an overview of the
  GeneScience Pharmaceuticals Co., Ltd.s
  pharmaceutical research and development
  focus.This report provides comprehensive
  information on the current therapeutic
  developmental pipeline of GeneScience
  Pharmaceuticals Co., Ltd.s, complete with
  comparative analysis at various stages,
  therapeutics assessment by drug target, mechanism
  of action (MoA), route of administration (RoA)
  and molecule type. It also reviews latest
  updates, and featured news and press releases,
  along with special features on late-stage and
  discontinued projects.
• "GeneScience Pharmaceuticals Co., Ltd. - Product
  Pipeline Review - 2014"report features
  investigational drugs from across globe covering
  over 20 therapy areas and nearly 3,000
  indications. The report is built using data and
  information sourced from Global Markets Directs
  proprietary databases, Company/University
  websites, SEC filings, investor presentations and
  featured press releases from company/university
  sites and industry-specific third party sources,
  put together by Global Markets Directs team.

4
Summary

• Drug profiles/records featured in the report
  undergoes periodic updation following a stringent
  set of processes that ensures that all the
  profiles are updated with the latest set of
  information. Additionally, processes including
  live news deals tracking, browser based
  alert-box and clinical trials registries tracking
  ensure that the most recent developments are
  captured on a real time basis.The report
  enhances decision making capabilities and help to
  create effective counter strategies to gain
  competitive advantage. It strengthens RD
  pipelines by identifying new targets and MOAs to
  produce first-in-class and best-in-class
  products.Note Certain sections in the report
  may be removed or altered based on the
  availability and relevance of data for the
  indicated disease.

5
Scope

• - The report provides brief overview of
  GeneScience Pharmaceuticals Co., Ltd. including
  business description, key information and facts,
  and its locations and subsidiaries- The report
  reviews current pipeline of GeneScience
  Pharmaceuticals Co., Ltd.s human therapeutic
  division and enlists all their major and minor
  projects- The report features product
  description and descriptive mechanism of action
  for key pipeline products along with the
  products developmental history and major
  milestones - Special feature on out-licensed and
  partnered product portfolio- The report
  summarizes all the dormant and discontinued
  pipeline projects- Latest company statement -
  Latest news and deals relating to the GeneScience
  Pharmaceuticals Co., Ltd.s pipeline products

6
Reasons to buy

• - Evaluate GeneScience Pharmaceuticals Co.,
  Ltd.s strategic position with total access to
  detailed information on its product pipeline-
  Assess the growth potential of GeneScience
  Pharmaceuticals Co., Ltd. in its therapy areas of
  focus- Identify new drug targets and therapeutic
  classes in the GeneScience Pharmaceuticals Co.,
  Ltd.s RD portfolio and develop key strategic
  initiatives to reinforce pipeline in those
  areas- Exploit in-licensing opportunities by
  identifying windows of opportunity to fill
  portfolio gaps- Develop strategic initiatives by
  understanding the focus areas of GeneScience
  Pharmaceuticals Co., Ltd. and exploit
  collaboration and partnership opportunities-
  Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive
  advantage- Plan mergers and acquisitions
  effectively by identifying the most promising
  pipeline of GeneScience Pharmaceuticals Co.,
  Ltd.- Develop and design in-licensing and
  out-licensing strategies by identifying
  prospective partners with the most attractive
  projects to enhance and expand business potential
  and scope

7
Table of Content
GeneScience Pharmaceuticals Co., Ltd. - Drug
Profiles 11Gensci-006 11Product Description
11Mechanism of Action 11RD Progress
11Gensci-007 12Product Description 12Mechanism
of Action 12RD Progress 12Gensci-008
13Product Description 13Mechanism of Action
13RD Progress 13Gensci-003 14
8
Table of Content
Product Description 14Mechanism of Action 14RD
Progress 14Gensci-028 15Product Description
15Mechanism of Action 15RD Progress
15GeneScience Pharmaceuticals Co., Ltd. -
Pipeline Analysis 16GeneScience Pharmaceuticals
Co., Ltd. - Pipeline Products by Molecule Type
16GeneScience Pharmaceuticals Co., Ltd. -
Dormant Projects 17GeneScience Pharmaceuticals
Co., Ltd. - Locations And Subsidiaries 18Head
Office 18Appendix 19Methodology 19Coverage
19Secondary Research 19
9
List Of Tables

• GeneScience Pharmaceuticals Co., Ltd., Key
  Information 4GeneScience Pharmaceuticals Co.,
  Ltd., Key Facts 4GeneScience Pharmaceuticals
  Co., Ltd. - Pipeline by Indication, 2014
  6GeneScience Pharmaceuticals Co., Ltd. -
  Pipeline by Stage of Development, 2014
  7GeneScience Pharmaceuticals Co., Ltd. -
  Monotherapy Products in Pipeline, 2014
  8GeneScience Pharmaceuticals Co., Ltd. -
  Preclinical, 2014 9GeneScience Pharmaceuticals
  Co., Ltd. - Unknown, 2014 10GeneScience
  Pharmaceuticals Co., Ltd. - Pipeline by Molecule
  Type, 2014 16GeneScience Pharmaceuticals Co.,
  Ltd. - Dormant Developmental Projects,2014 17  

10
List of Figures

• GeneScience Pharmaceuticals Co., Ltd. - Pipeline
  by Top 10 Indication, 2014 6GeneScience
  Pharmaceuticals Co., Ltd. - Pipeline by Stage of
  Development, 2014 7GeneScience Pharmaceuticals
  Co., Ltd. - Monotherapy Products in Pipeline,
  2014 8GeneScience Pharmaceuticals Co., Ltd. -
  Pipeline by Top 10 Molecule Type, 2014 16

11
Related Reports

• Global Neurosurgery Market 2015-2019
• Active Pharmaceutical Ingredients (API) Market in
  India 2015-2019
• BrainStorm Cell Therapeutics Inc. (BCLI) -
  Financial and Strategic SWOT Analysis Review
• Ampio Pharmaceuticals, Inc. (AMPE) - Financial
  and Strategic SWOT Analysis Review
• MiMedx Group, Inc (MDXG) - Financial and
  Strategic SWOT Analysis Review

12
Related Reports

• Threshold Pharmaceuticals, Inc. (THLD) -
  Financial and Strategic SWOT Analysis Review
• MEI Pharma, Inc. (MEIP) - Financial and Strategic
  SWOT Analysis Review
• Titan Pharmaceuticals, Inc. (TTNP) - Financial
  and Strategic SWOT Analysis Review
• RedHill Biopharma Ltd. (RDHL) - Financial and
  Strategic SWOT Analysis Review
• Pharmaceuticals Healthcare Market Research
  Reports

13

• GeneScience Pharmaceuticals Co., Ltd. - Product
  Pipeline Review 2014
• Published Oct 2014 20 Pages
• GeneScience Pharmaceuticals Co., Ltd. - Product
  Pipeline Review - 2014report features
  investigational drugs from across globe covering
  over 20 therapy areas and nearly 3,000
  indications
  Price

Format Price
PDF 1500
Site Licence 3000
Enterprise Wide Licence 4500
14
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953

• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news